Searching News Database: Nanoengineering
HSMN NewsFeed - 16 Dec 2015
BIND Therapeutics Appoints Jonathan Yingling, Ph.D., as Chief Scientific Officer
BIND Therapeutics Appoints Jonathan Yingling, Ph.D., as Chief Scientific Officer
Additional items found! 1
Members Archive contains
1 additional stories matching:
Nanoengineering
(Password required)
Nanoengineering
(Password required)